Previous close | 2.2800 |
Open | 2.4232 |
Bid | 2.1100 x 800 |
Ask | 2.4400 x 1100 |
Day's range | 2.2100 - 2.3700 |
52-week range | 1.6200 - 4.0500 |
Volume | |
Avg. volume | 19,160 |
Market cap | 60.751M |
Beta (5Y monthly) | -1.32 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.4600 |
Earnings date | 08 Feb 2024 - 12 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 6.50 |
AUSTIN, Texas, November 14, 2023--Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates
Here is how Anebulo Pharmaceuticals, Inc. (ANEB) and Conmed (CNMD) have performed compared to their sector so far this year.
AUSTIN, Texas, October 06, 2023--Anebulo Pharmaceuticals Announces New CEO